Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Laboratory of Computational and Functional Oncology, Department for Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy.
Nat Commun. 2020 Oct 8;11(1):5086. doi: 10.1038/s41467-020-18854-2.
Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide pandemic with substantial mortality. Immune mediated damage has been proposed as a pathogenic factor, but immune responses in lungs of COVID-19 patients remain poorly characterized. Here we show transcriptomic, histologic and cellular profiles of post mortem COVID-19 (n = 34 tissues from 16 patients) and normal lung tissues (n = 9 tissues from 6 patients). Two distinct immunopathological reaction patterns of lethal COVID-19 are identified. One pattern shows high local expression of interferon stimulated genes (ISG) and cytokines, high viral loads and limited pulmonary damage, the other pattern shows severely damaged lungs, low ISGs (ISG), low viral loads and abundant infiltrating activated CD8 T cells and macrophages. ISG patients die significantly earlier after hospitalization than ISG patients. Our study may point to distinct stages of progression of COVID-19 lung disease and highlights the need for peripheral blood biomarkers that inform about patient lung status and guide treatment.
新型冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的呼吸道疾病,现已在全球范围内大流行,死亡率较高。免疫介导损伤被认为是一种致病因素,但 COVID-19 患者肺部的免疫反应仍未得到充分描述。在这里,我们展示了 COVID-19(n = 16 名患者的 34 个组织)和正常肺组织(n = 6 名患者的 9 个组织)的死后转录组、组织学和细胞特征。确定了两种具有致命性的 COVID-19 不同的免疫病理反应模式。一种模式显示干扰素刺激基因(ISG)和细胞因子的局部表达水平较高,病毒载量较高,肺部损伤有限;另一种模式显示肺部严重受损,ISG 水平较低(ISG),病毒载量低,大量浸润的活化 CD8 T 细胞和巨噬细胞。住院后,ISG 患者的死亡时间明显早于 ISG 患者。我们的研究可能指向 COVID-19 肺部疾病的不同进展阶段,并强调需要外周血生物标志物来了解患者肺部状况并指导治疗。